Skip to main content

Table 1 Baseline characteristics of patients in the lower-TG (150 mg/dl) and higher-TG (>150 mg/dl) groups

From: Lower serum triglyceride level is a risk factor for in-hospital and late major adverse events in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention- a cohort study

  Lower-TG group Higher-TG group P
N 163 84  
Age, yrs 67.1 ± 13.2 56.1 ± 11.3 <0.001
Female (%) 22 (13.6) 19 (22.6) 0.100
Hypertension (%) 97 (59.5) 61 (72.6) 0.058
DM (%) 46 (28.2) 34 (40.5) 0.071
Smoking (%) 99 (60.7) 56 (66.7) 0.439
BMI, kg/m 2 24.1 ± 3.5 26.3 ± 3.2 <0.001
Previous CAD (%) 22 (13.5) 5 (6.0) 0.113
Previous stroke (%) 15 (9.2) 5 (6.0) 0.522
Carotid stenosis (%) 4 (2.5) 0 (0) 0.303
PAD (%) 3 (1.8) 2 (2.4) 1.000
eGFR, ml/min 46.7 ± 18.5 57.6 ± 20.5 <0.001
Previous hypolipid drugs
Statin 21 (12.9) 12 (14.3) 0.913
Fibrate 1 (0.6) 3 (3.6) 0.115
Admission lipid profile    
HDL, mg/dl 45.4 ± 10.8 37.4 ± 8 <0.001
LDL, mg/dl 100.9 ± 31.6 106.6 ± 41.4 0.231
TC/HDL 3.65 ± 0.87 5.02 ± 1.36 <0.001
LDL/HDL 2.32 ± 0.81 2.93 ± 1.28 <0.001
TG, mg/dl (range) 83.6 ± 34.3 (13–149) 258.6 ± 136.8 (152–805) <0.001
Cardiogenic shock (%) 29 (17.8) 7 (8.3) 0.071
  1. BMI, body mass index; CAD, coronary artery disease; DM, diabetes mellitus; eGFR, estimated glomerular filtration rate; HDL, high-density lipoprotein; LDL, low-density protein; PAD, peripheral arterial disease; TC, total cholesterol; TG, triglyceride.